Cargando…

Pioglitazone and thyroid cancer risk in patients with type 2 diabetes

Detalles Bibliográficos
Autor principal: Tseng, Chin-Hsiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072996/
http://dx.doi.org/10.1186/2049-3002-2-S1-P77
_version_ 1782323051167219712
author Tseng, Chin-Hsiao
author_facet Tseng, Chin-Hsiao
author_sort Tseng, Chin-Hsiao
collection PubMed
description
format Online
Article
Text
id pubmed-4072996
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40729962014-07-01 Pioglitazone and thyroid cancer risk in patients with type 2 diabetes Tseng, Chin-Hsiao Cancer Metab Poster Presentation BioMed Central 2014-05-28 /pmc/articles/PMC4072996/ http://dx.doi.org/10.1186/2049-3002-2-S1-P77 Text en Copyright © 2014 Tseng; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Tseng, Chin-Hsiao
Pioglitazone and thyroid cancer risk in patients with type 2 diabetes
title Pioglitazone and thyroid cancer risk in patients with type 2 diabetes
title_full Pioglitazone and thyroid cancer risk in patients with type 2 diabetes
title_fullStr Pioglitazone and thyroid cancer risk in patients with type 2 diabetes
title_full_unstemmed Pioglitazone and thyroid cancer risk in patients with type 2 diabetes
title_short Pioglitazone and thyroid cancer risk in patients with type 2 diabetes
title_sort pioglitazone and thyroid cancer risk in patients with type 2 diabetes
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072996/
http://dx.doi.org/10.1186/2049-3002-2-S1-P77
work_keys_str_mv AT tsengchinhsiao pioglitazoneandthyroidcancerriskinpatientswithtype2diabetes